Showing results (181-190 of 1,276) with videos related to
Sort By:
Pageof 128
Seminars in Radiation Oncology|December 28, 2005
Radiation combined with antiangiogenic and antivascular agentsMichael S O'ReillySeminars in Radiation Oncology|December 28, 2005
Radiation and new molecular agents part I: targeting ATM-ATR checkpoints, DNA repair, and the proteasomeAnanya Choudhury, Andrew Cuddihy, Robert G BristowSeminars in Radiation Oncology|September 16, 2014
Bevacizumab and other targeted agents in the upfront treatment of glioblastomaJennifer L ClarkeSeminars in Radiation Oncology|September 4, 2017
Imaging Radiation-Induced Normal Tissue Injury to Quantify Regional Dose ResponseDavid V Fried, Shiva K Das, Lawrence B MarksSeminars in Radiation Oncology|September 19, 2015
DNA Damage Response Assessments in Human Tumor Samples Provide Functional Biomarkers of RadiosensitivityHenning Willers, Liliana Gheorghiu, Qi Liu, et al.Seminars in Radiation Oncology|September 19, 2015
Hypoxia and Predicting Radiation ResponseRichard P Hill, Robert G Bristow, Anthony Fyles, et al.Seminars in Radiation Oncology|November 28, 2017
Therapeutic Implications of the Genetic Landscape of Head and Neck CancerJanice Cho, Daniel E Johnson, Jennifer R GrandisSeminars in Radiation Oncology|November 28, 2017
Molecular Imaging-Guided Radiotherapy for the Treatment of Head-and-Neck Squamous Cell Carcinoma: Does it Fulfill the Promises?Vincent Grégoire, Daniela Thorwarth, John Aldo LeeSeminars in Radiation Oncology|August 30, 2008
Clinical experience shows that catastrophic late effects associated with ablative fractionation can be avoided by technological innovationBrian KavanaghSeminars in Radiation Oncology|August 30, 2008
The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fractionDavid J BrennerPageof 128